Avoiding litigation is usually a better option than defending it. With their fingers firmly on the pulse of how the courts assess infringement and validity of rights, our contentious IP teams are ideally placed to assist in assessing the risks involved in any new project, no matter what the sector or technology.

Launching a new product or using a new process is seldom risk-free. At least a part of that risk can be managed by an assessment of the IP landscape. Whether the issue arises in a sector where the IP rights concerned are brands, or one where only patents are in issue, we can provide specialists in those areas. For international clearance we can coordinate advice as necessary.

If general freedom to operate advice is required, our contentious IP teams can arrange for relevant searches to be conducted, and then examine the results through the eyes of experienced litigators. Our regulatory team has extensive experience helping clients navigate regulatory requirements and exclusivities. If a particular risk has already been identified on which specialist advice is required, we can provide a bespoke opinion.

If a particular risk is identified, we can advise on the magnitude of that risk, how it might be lessened (for example by modifications), or whether pre-emptive steps might be taken to challenge existing rights and/or seek a declaration of non-infringement. Of particular concern may be that a product launch may be met with an application for an interim injunction. Again our wealth of litigation experience is crucial in giving the right advice.

In some cases it may be desirable to seek a licence to operate. In such cases, our commercial & IP transactions team can advise on the right type of arrangement and conduct, or help in the conduct of, negotiations as required.

In all cases we offer pragmatic, practical advice. We are also happy to accommodate the inevitable budgetary constraints by showing flexibility in fee arrangements.

Key contact

Ian Gruselle

Contact

Myles Jelf

Contact

Experience

Global oil company: review of competitor patents in the fuel additive space prior to the launch of a new fuel product

Major innovative pharmaceutical company

Latest articles

What others say

“The team was equally willing to embrace and incorporate new concepts, and their general approach was to always look to provide solutions or alternative ways to achieve the right outcomes.”

Chambers and Partners 2020

“It’s a very impressive firm. They deliver excellent service and they’re focused on client delivery.”

Chambers and Partners 2020

“It is a high-quality team of practical thinkers who know what is needed in business.”

Chambers and Partners 2020

“Noted for particular strength in IP litigation and the licensing of telecoms SEPs.”

Chambers and Partners 2020

“They really do invest in the relationship”

Chambers and Partners 2020

Recent rankings and awards

Life Sciences - Band 1
Chambers and Partners UK 2020/2019